BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22618270)

  • 1. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y; Watanabe A; Goto H; Matsushima T; Abe S; Aoki N; Shimokata K; Mikasa K; Niki Y; Kohno S
    J Infect Chemother; 2012 Aug; 18(4):544-51. PubMed ID: 22618270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of garenoxacin tablets on bacterial pneumonia: postmarketing surveillance in Japan.
    Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
    J Infect Chemother; 2014 Sep; 20(9):549-57. PubMed ID: 24934887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 6. Community-acquired Haemophilus influenzae pneumonia--New insights from the CAPNETZ study.
    Forstner C; Rohde G; Rupp J; Schuette H; Ott SR; Hagel S; Harrison N; Thalhammer F; von Baum H; Suttorp N; Welte T; Pletz MW;
    J Infect; 2016 May; 72(5):554-63. PubMed ID: 26940505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
    Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
    J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological study of pneumococcal infection and Haemophilus influenzae infection].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():4-10. PubMed ID: 12638134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R; Rikimaru T; Aizawa H; Kawayama T
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of twice-daily administration of CTDR].
    Ogata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():98. PubMed ID: 12638156
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    Sakata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan.
    Yamamoto Y; Izumikawa K; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Tsukamoto M; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
    J Infect Chemother; 2013 Apr; 19(2):291-8. PubMed ID: 23345050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological study of pneumococcal infections and Haemophilus influenzae infections in the last three years].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():72-9. PubMed ID: 12638146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isolation of bacteria and treatment of patients with pneumococcal and Haemophilus influenzae infections].
    Suzuki K
    Jpn J Antibiot; 2001 May; 54 Suppl B():97. PubMed ID: 12638155
    [No Abstract]   [Full Text] [Related]  

  • 20. Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.
    Strålin K; Olcén P; Törnqvist E; Holmberg H
    Scand J Infect Dis; 2010 Jul; 42(6-7):426-34. PubMed ID: 20141490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.